Hyderabad Telangana, India

Arutla Srinivas

This inventor holds 2 USPTO granted patents. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arutla Srinivas. Retrieved from https://idiyas.com/inventor/arutla-srinivas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arutla Srinivas: Innovator in Drug Delivery Systems

Introduction

Arutla Srinivas is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of drug delivery systems, holding a total of 2 patents. His work focuses on developing innovative compositions that enhance the efficacy of drug delivery.

Latest Patents

Srinivas's latest patents include compositions for drug delivery that feature substantially non-porous polymeric microparticles. These microparticles comprise a hydrophobic polymer and a plasticizer, containing therein a bioactive or bioinactive agent. This innovative approach aims to improve the delivery and effectiveness of pharmaceutical agents.

Career Highlights

Arutla Srinivas is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. His role at the company allows him to apply his expertise in drug delivery systems to real-world applications.

Collaborations

Srinivas has collaborated with notable colleagues, including Vakati Venkat Arvind and Saravana Perumal. These collaborations have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Arutla Srinivas is a dedicated inventor whose work in drug delivery systems is paving the way for advancements in pharmaceutical technology. His contributions are vital to improving patient outcomes and enhancing the effectiveness of medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…